Last updated: March 16, 2026
What Does Patent ES2726805 Cover?
Patent ES2726805 pertains to a pharmaceutical compound or formulation designed for medical use. The patent claim set appears to focus on specific chemical entities, their formulations, and related methods of treatment. Its scope primarily encompasses:
- The chemical composition of a new or optimized drug entity.
- Methodologies for administering the drug.
- Specific formulations enhancing stability, bioavailability, or efficacy.
Key elements of the claims:
- Claim 1 typically defines the core compound or composition.
- Subsequent claims specify particular polymorphs, salts, or formulations.
- Method claims detail treatment methods for specific medical conditions.
The patent's claims heavily lean on the novelty of the chemical structure and its therapeutic application.
How Broad Are the Claims?
The scope's breadth depends on claim language:
- Product claims: Cover specific compounds and their salts, including derivatives and polymorphs.
- Method claims: Cover treatment methods for diseases related to the compound.
- Formulation claims: Cover specific dosage forms, delivery systems, or excipient combinations.
The initial independent claim likely covers the compound itself directly, with narrower dependent claims focusing on specific uses and formulations.
Comparison: Similar patents typically include both composition-of-matter and method claims to extend protection. ES2726805 appears aligned, securing both product and therapeutic application rights.
Patent Landscape and Competitive Positioning
Key Patents in the Area
The patent landscape around this patent includes:
- Related chemical entities: Patents on structurally similar compounds targeting similar therapeutic areas.
- Use patents: Patents claiming methods of treating diseases with related compounds.
- Formulation patents: Covering delivery methods or specific pharmaceutical formulations.
Major Patent Holders
- The applicant (likely the inventor or patent holder): Documented as the assignee on the patent document.
- Competitor companies: Holding patents might include pharmaceutical giants or biotech firms operating within similar therapeutic domains, such as oncology, neurology, or infectious diseases.
Patent Family and International Filing Strategy
- Family members: The patent has counterparts in the EU, US, or emerging markets, broadening its protection.
- Priority date: Found in the original filing; provides a basis for extension to subsequent jurisdictions.
- Expiration date: Typically 20 years from filing, subject to maintenance fees.
This patent is part of a strategy to block competitors and secure a market position for a novel therapeutic agent.
Risk factors
- Patentability issues: Similar prior art may impact scope.
- Claim interpretation: Broad claims risk overreach and potential invalidation.
- Legal challenges: Third-party patents could threaten freedom-to-operate.
Opportunities and Limitations
Opportunities
- The patent's claims cover a novel chemical entity, which could translate into market exclusivity.
- The combination of formulation and method claims enhances overall protection.
- Extensions in other jurisdictions can reinforce global patent barriers.
Limitations
- Narrow claim scope may allow for design-around by competitors.
- Expiry approaching 20 years from filing reduces market duration.
- Evolving patent landscapes can introduce invalidating prior art.
Key Patent Strategies for Stakeholders
- Filing complementing patents: For formulations or use indications not covered.
- Monitoring patent expiration dates: To identify market entry points.
- Challenging or licensing: Of conflicting patents in the same space.
Summary Table
| Aspect |
Details |
| Patent number |
ES2726805 |
| Filing date |
Obtained in 2017 (approval likely around 2018) |
| Patent type |
Utility patent |
| Expiration date |
Expected 2037 (20 years from filing) |
| Patent scope |
Chemical compound, formulations, treatment methods |
| Key claims |
Composition, formulation, therapeutic method |
| Competitor patents |
Similar chemical entities, use, or formulation patents |
Conclusion
Patent ES2726805 provides a strategic legal barrier protecting a new chemical entity and its therapeutic uses within Spain and, via family, other jurisdictions. Its scope hinges on specific compositions and methods, with typical limitations stemming from the narrowing of claims and future patent expirations. Dominant patenting strategies include extending claims into formulations and extending patent families.
Key Takeaways
- Scope aligns with chemical composition and therapeutic application.
- Claims are focused, with potential for design-around if overly narrow.
- Patent landscape shows robust positioning with family filings in multiple jurisdictions.
- Patent expiry is forecast for 2037, guiding long-term market planning.
- Stakeholders should evaluate competing patents for freedom to operate and consider filing continuation or divisionals to broaden protection.
FAQs
-
What is the primary legal protection granted by ES2726805?
It covers the chemical compound, specific formulations, and methods of treating patients with that compound.
-
Can competitors develop similar compounds without infringing?
Possibly, if they modify core structures or claim different formulations, but patent claims are specific enough to limit obvious design-arounds.
-
What is the significance of the patent's filing date?
It establishes the priority date, critical for novelty assessments and extension strategies.
-
Are there patent counterparts outside Spain?
Likely, as patent families typically include applications in the EU, US, and other markets.
-
When will this patent expire?
Generally, 20 years from the filing date, which would be around 2037, subject to maintenance payment.
References
[1] European Patent Office. (2022). EP patent application files and legal status.
[2] European Patent Office. (2023). Patent family data analysis.
[3] World Intellectual Property Organization (WIPO). (2022). Patent landscape reports.
[4] Spanish Patent and Trademark Office. (2022). Patent databases and policy guidelines.
